STAT3 and neoplasm: Converse to our hypotheses, Kaplan–Meier survival analysis showed low tumour nuclear (surrogate marker of activation) expression of STAT3 was significantly associated with reduced outcome in the full cohort (HR = 0.671, 95% CI: 0.469–0.961, log rank p = 0.029) (Figure 5K).